Biosimilars

[Biosimilars @Biosimilars3]

Latest updates:
1. First Treatment for Children With SLE Gets #FDA Approval
2. #NDA for Once-Monthly Injectable #HIV Treatment Submitted to #FDA
3. #Darolutamide Gets Priority Review for #NonMetastatic #Castration-Resistant #Prostate #Cancer

[Biosimilars @Biosimilars3]

Today News
1. #Skyrizi Approved for Moderate to Severe Plaque #Psoriasis.
2. Investigational Treatment for #Hypereosinophilic Syndrome Granted #Orphan Drug Status
3. Novel Reversal Agent for #Ticagrelor Gets #FDA’s Breakthrough #TxDesignation

[Biosimilars @Biosimilars3]

Latest Updates
1. #FDA Approves Novel Non-Surgical Device for #Weight Reduction in #Obese Patients
2. #KardioMobile Device Gets #FDA Clearance for #Bradycardia, #Tachycardia Detection
3. #FDA to Review IV-Administered #Eptinezumab for Migraine Prevention

[Biosimilars @Biosimilars3]

Latest Updates
Latest Updates:
1. #Keytruda Combination Therapy Approved as First-Line Treatment of Advanced #RCC
2. The risk for #T2DM Increased With Use of #5α-Reductase #Inhibitors
3. First #Generic #Naloxone Nasal Spray Gets FDA Approval.

[Biosimilars @Biosimilars3]

Latest Updates:
1. #Kidney Disorder Risk Examined in Various #Bipolar #Disorder Drug Regimens
2. #AntiInflammatory Add May Be Beneficial for #Depression
3. #UB421Monotherapy Maintains #HIV Viral Suppression
4. #Turmeric supplement Linked to #Patient’s #Iron #Deficiency #Anemia

[Biosimilars @Biosimilars3]

Biosimilars updates:
1. Biosimilar drug packaging does not meet EU guidelines on readability
2. Rituximab biosimilar Truxima approved in Canada
3. Celltrion has renewed success with leukemia biosimilar Truxima and expands markets in Europe and Latin America

[Biosimilars @Biosimilars3]

Latest Updates
1. Evidence Supporting #Niacin Use for #Cardiovascular #Disease Prevention Evaluated
2. Barriers to #Opioid Use Disorder Treatment Should Be Addressed.
3. #Elafibranor Gets Breakthrough Therapy #Designation for Primary #Biliary #Cholangitis.

[Biosimilars @Biosimilars3]

@bmj_latest Updates
1. #Bijuva Launched for Moderate to Severe #HotFlashes Due to #Menopause
2. #Mouthwashes Show Promise in Reducing #ChemoRelated #Oral #Mucositis #Pain
3. #FDA Orders Manufacturers to Stop Selling #SurgicalMesh for #Transvaginal Repair of #Pelvic #Organprolaps

[Biosimilars @Biosimilars3]

Latest Updates
1. First-in-Class, #Targeted #Therapy Approved for #Metastatic #Bladder #Cancer.
2. #CDC Clarifies Guideline on #Opioid Prescribing for #ChronicPain.
3. #Canagliflozin Lowers #ESRD Risk in #Diabetic #Kidney #Disease.
4. #Pamrevlumab Gets #OrphanDrugDesignation.

[Biosimilars @Biosimilars3]

@ProfoundFatigue Need you mail ID/ Contact number to discuss few important issues

[Biosimilars @Biosimilars3]

Latest Updates on Biosimilars
1. WHO releases Q&A on biosimilars evaluation
2. EC approval for adalimumab biosimilar Idacio
3.Efficacy and safety of bevacizumab biosimilar ABP 215
4. Novo Nordisk granted exclusivity on GLP-1 agonist Victoza until 2023
https://t.co/tIDMQ5SswT

[Biosimilars @Biosimilars3]

Latest news from FDA
1. FDA Issues Safety Labeling Change Order for Female Libido Pill
2. CDC: Superbug Fungus Has Sickened 600 Americans
For more details visit https://t.co/tIDMQ5SswT
[email protected]

[Biosimilars @Biosimilars3]

Latest News
1. #FDA Cracks Down on #Companies Selling #ELiquids Resembling #Prescription #Cough #Meds
2. #FDA Warns Against the Use of Unapproved #Devices Marketed for Assessing #HeadInjury

[Biosimilars @Biosimilars3]

Latest News from FDA
1. FDA Rejects Zynquista NDA for Type 1 Diabetes Treatment.
2. FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma

For more details visit https://t.co/tIDMQ6a3Vt
[email protected]

[Biosimilars @Biosimilars3]

Latest news and Updates:
1. #FDA: #Seizures Reported Following #E-Cigarette Use
2. #FDA Approves Novel #Device for Treating Heavy #Menstrual #Bleeding
3. #FDA to Review #Istradefylline #NDA for #Parkinson #Disease Again

[Biosimilars @Biosimilars3]

Todays news
1. #FDA Approves First #GenericVersions of #Letairis, Adds New REMS Program.
2. Japanese approval for #Lupin’s #etanercept #biosimilar.
3. Use of #biosimilars in #oncology in Europe.

[Biosimilars @Biosimilars3]

Latest Updates
1. #FDA Clears Unique Medical Device for #Anxiety, #Depression, #Insomnia Treatment.
2. #Antihistamine-Releasing Contact Lens Looks Promising in #Phase3Trials

[Biosimilars @Biosimilars3]

New @Biotech_Updates 1. Novel #Androgen May Be a Potential Candidate for #Male #Hormonal #Contraceptive.
2. First #Generic Version of #Remodulin Available for PAH
3. #Ozanimod NDA Submitted for Treatment of #Relapsing Multiple #Sclerosis

[Biosimilars @Biosimilars3]

Latest Updates on Biosimilars
1. #FDA proposes update to #biosimilar naming guideline
2. #FDA approves #trastuzumab #biosimilar #Trazimera.